Cure Rare Disease
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1575 Tremont St Apt 1107, Boston, Massac...Phone Number
(607) 215-6401Website
www.cureraredisease.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Cure Rare Disease
Cure Rare Disease is a non-profit organization focused on developing advanced therapeutics for individuals diagnosed with rare, genetic diseases that currently lack treatment options. Through collaboration with world-renowned researchers, the organization aims to create life-saving therapies that can halt or reverse disease progression. Their innovative drug development model seeks to streamline and de-risk the process of creating treatments for ultra-rare diseases, ensuring that patients have access to potential cures. The organization partners with academic researchers, patient families, and biotech firms to build a comprehensive ecosystem for addressing neglected diseases.Explore more
Cure Rare Disease Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cure Rare Disease your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cure Rare Disease
Click to see if Cure Rare Disease had a recent Job posting/layoffs
Check if Cure Rare Disease has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cure Rare Disease is spiking on competitors!
Earning: See what the market has to say on Cure Rare Disease recently announced quarterly report
Cure Rare Disease, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Cure Rare Disease launches new products
Funding: Get notified immidiatlly once Cure Rare Disease has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Cure Rare Disease
Compare insights from companies similar to Cure Rare Disease, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cure Rare Disease is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cure Rare Disease is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cure Rare Disease.
Cure Rare Disease financials insights
Gather financial insights about Cure Rare Disease, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$19K
Cure Rare Disease Tech Stack
A closer look at the technologies used by Cure Rare Disease
Cure Rare Disease News & Media
Cure Rare Disease Welcomes New Scientific and Strategic Leaders to Advance Therapies for Ultra-Rare Conditions
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD), a clinical-stage nonprofit biotechnology organization developing genetic therapies for ultra-rare conditions, is proud to announce the appointment of Keith Sutton, PhD, as Chief Science Officer and the addition of Michelle Werner to its Board of Directors. These strategic additions bring deep scientific expertise and seasoned biopharmaceutical leadership to CRD as the organization continues to advance therapeutic development for rareCure Rare Disease Receives Orphan Drug Designation from FDA for Investigational Therapy Targeting Spinocerebellar Ataxia Type 3 (SCA3)
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD), a clinical-stage nonprofit biotechnology company developing genetic medicines for ultra-rare and rare conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational anti-sense Oligonucleotide therapeutic for the treatment of Spinocerebellar Ataxia (SCA), including Spinocerebellar Ataxia Type 3 (SCA3), a progressive and currently untreatable neurodegenerativWe Row For William: 157 Miles, One Nonstop Journey of Hope
MEDFORD, Ore.--(BUSINESS WIRE)--On April 25, Joe Jackson and a dedicated crew of men including Jeremy Leever and Shaun Olson will embark on an extraordinary nonstop, overnight rowing journey covering 157 miles of the Rogue River to raise awareness and critical funds for his son, William Jackson, who is battling Duchenne muscular dystrophy (DMD). What typically takes 10 days, Joe and his crew will complete in a single, grueling push, symbolizing the urgency of finding aCure Rare Disease Awarded $5.69 Million CIRM Grant to Advance Gene Therapy for Spinocerebellar Ataxia Type 3
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the development of an antisense oligonucleotide therapy for spinocerebellar ataxia type 3 (SCA3), a neurodegenerative disorder with no current treatment. Cure Rare Disease launched its SCA3 program in 2021 to develop an antisense oligonucleotide (ASO) therapy, with initial funding support provided by Gregory Kla
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cure Rare Disease
Sign Up For FreeTo access detailed company insights
Cure Rare Disease is a non-profit organization focused on developing advanced therapeutics for individuals diagnosed with rare, genetic diseases that currently lack treatment options. Through collaboration with world-renowned researchers, the organization aims to create life-saving therapies that can halt or reverse disease progression. Their innov... Read More
